Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer ...
The hope with CAR T cell therapies for autoimmune disease is that they can reset the immune system and induce deep remission. But recent trial pauses have renewed concerns about safety, patient ...
Researchers used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, ...
("PeriNess"), has informed the Company that the first patient has been dosed in an investigator-initiated clinical study evaluating systemic recombinant human DNase in combination with anti-CD19 CAR T ...
In a study of fingertip regeneration, a team led by JAX senior research scientist James Godwin found that some immune cells ...
The International Society for Cell & Gene Therapy (ISCT) is proud to recognize the contributions of its leaders to the ...
T cells as potent killers of small-cell lung cancer, with their genetic signature potentially revealing patients who could ...
Cancer immunotherapy can lose its punch when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer ...
Expression Therapeutics, Inc., a clinical-stage gene and cell therapy company, today announced that NCI SBIR within the National Institutes of Health (NIH) has awarded a Phase II grant of $2,058,885 ...
Ralph V. Boccia, MD, FACP, explained why CAR T-cell therapy followed by bispecific antibodies may be the preferred sequence at first relapse in multiple myeloma.
The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results